Weir DG - Search Results

1

Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.

Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM. Ward M, et al. Among authors: weir dg. QJM. 1997 Aug;90(8):519-24. doi: 10.1093/qjmed/90.8.519. QJM. 1997. PMID: 9327030 Clinical Trial.

2

Fluctuations in dietary methionine intake do not alter plasma homocysteine concentration in healthy men.

Ward M, McNulty H, Pentieva K, McPartlin J, Strain JJ, Weir DG, Scott JM. Ward M, et al. Among authors: weir dg. J Nutr. 2000 Nov;130(11):2653-7. doi: 10.1093/jn/130.11.2653. J Nutr. 2000. PMID: 11053502 Clinical Trial.

3

Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete.

McKinley MC, McNulty H, McPartlin J, Strain JJ, Pentieva K, Ward M, Weir DG, Scott JM. McKinley MC, et al. Among authors: weir dg. Am J Clin Nutr. 2001 Apr;73(4):759-64. doi: 10.1093/ajcn/73.4.759. Am J Clin Nutr. 2001. PMID: 11273851 Clinical Trial.

4

Effect of supplemental methionine on plasma homocysteine concentrations in healthy men: a preliminary study.

Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM. Ward M, et al. Among authors: weir dg. Int J Vitam Nutr Res. 2001 Jan;71(1):82-6. doi: 10.1024/0300-9831.71.1.82. Int J Vitam Nutr Res. 2001. PMID: 11276928 Free article.

5

Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.

Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG, Scott JM. Quinlivan EP, et al. Among authors: weir dg. Lancet. 2002 Jan 19;359(9302):227-8. doi: 10.1016/s0140-6736(02)07439-1. Lancet. 2002. PMID: 11812560 Clinical Trial.

6

Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age.

Daly S, Mills JL, Molloy AM, Conley M, McPartlin J, Lee YJ, Young PB, Kirke PN, Weir DG, Scott JM. Daly S, et al. Among authors: weir dg. QJM. 2002 Nov;95(11):733-40. doi: 10.1093/qjmed/95.11.733. QJM. 2002. PMID: 12391385 Clinical Trial.

7

Homocysteine and cardiovascular disease.

Scott J, Weir D. Scott J, et al. QJM. 1996 Aug;89(8):561-3. doi: 10.1093/qjmed/89.8.561. QJM. 1996. PMID: 8935476 No abstract available.

8

Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implications for riboflavin requirements.

McNulty H, McKinley MC, Wilson B, McPartlin J, Strain JJ, Weir DG, Scott JM. McNulty H, et al. Among authors: weir dg. Am J Clin Nutr. 2002 Aug;76(2):436-41. doi: 10.1093/ajcn/76.2.436. Am J Clin Nutr. 2002. PMID: 12145019 Clinical Trial.

9

Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements.

Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Kelly P, et al. Among authors: weir dg. Am J Clin Nutr. 1997 Jun;65(6):1790-5. doi: 10.1093/ajcn/65.6.1790. Am J Clin Nutr. 1997. PMID: 9174474 Clinical Trial.

10

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.

Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Wald NJ, et al. Among authors: weir dg. Arch Intern Med. 1998 Apr 27;158(8):862-7. doi: 10.1001/archinte.158.8.862. Arch Intern Med. 1998. PMID: 9570171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters